Results 1 to 10 of about 963 (127)
Indian Journal of Dermatology, Venereology, and Leprology, 2016 Liszaj śluzowaty twardzinowy jest rzadką, postępującą mucynozą skórną, o potencjalnie śmiertelnych konsekwencjach. Rozpoznanie choroby wymaga stwierdzenia 4 cech: grudkowa liszajowata wysypka skórna o typowej lokalizacji; biopsja skóry wykazująca cechy ...
Olasiński, Jerzy
core +5 more sources
Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives. [PDF]
Exp DermatolJAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events.
Spadafora M +5 more
europepmc +3 more sources
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020 SummaryScleromyxedema is a rare, cutaneous deposition disorder from the group of mucinoses, which can affect multiple organs and is virtually always associated with a monoclonal gammopathy. Cutaneous manifestations are usually generalized, 2 to 3 mm sized, dome‐shaped or flat‐topped, waxy, slightly red to skin‐colored papules and sclerodermoid ...
Jochen H O, Hoffmann, Alexander H, Enk
openaire +4 more sources
Current Opinion in Rheumatology, 2014 To synthesize the current known data on pathogenesis and treatment of scleromyxedema. This review will also highlight the clinical presentation, systemic features and outcomes and distinguishing features between scleromyxedema and scleroderma, as a common mimic.Most recent publications have focused on describing treatment responses with novel therapies,
Ryan R, Bogner +2 more
openaire +5 more sources
Eosinophilic fasciitis (Shulman's disease): review and comparative evaluation of seven patients. [PDF]
, 2019 OBJECTIVES: Eosinophilic fasciitis (EF) was described in 1974 by Shulman as a rare fibrosing connective tissue disease of unknown etiology. An undetermined trigger is thought to lead to the degranulation of eosinophils that interact with fibroblasts and
Cimbron, M +3 more
core +1 more source
Mechanism of NSF: New evidence challenging the prevailing theory [PDF]
, 2009 Nephrogenic systemic fibrosis (NSF) has been associated with the administration of gadolinium-based contrast agents in patients with severely impaired renal function (SIRF), endstage renal disease (ESRD), or acute renal failure (ARF).
Jimenez, MD, Sergio A. +1 more
core +2 more sources
A Case of Multiple Myeloma Diagnosed by Skin Lesions [PDF]
, 2010 Multiple myeloma, being a malignant proliferation of plasma cells in the bone marrow, has clinical spectrum varying from monoclonal gammopathy with unknown significance to plasma cell leukemia.
Aylin Okçu Heper +3 more
core +1 more source
Absence of human herpes virus-8 (HHV8) in nephrogenic systemic fibrosis [PDF]
, 2008 Background Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder that exhibits CD34 expression in the majority of lesional spindle cells. Several features of NSF bear similarity to Kaposi sarcoma.
Pantanowitz Liron +2 more
core +1 more source
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: A systematic review [PDF]
, 2012 Glatiramer acetate and interferon-beta are approved first-line disease-modifying treatments (DMTs) for multiple sclerosis (MS). DMTs can be associated with cutaneous adverse events, which may influence treatment adherence and patient quality of life.
Alava C +20 more
core +1 more source
Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies [PDF]
, 2014 During recent years, an increasing number of neuromuscular diseases have been recognized either to be caused primarily by autoimmune mechanisms, or to have important autoimmune components.
Oliveira, Acary Souza Bulle +2 more
core +3 more sources